SCHEMBL20103604

SCHEMBL20103604

Cc1cc(OCc2nc3ccccc3n2C(=O)OC(C)(C)C)ccc1NC(=S)NC1=CC(C)(Cl)C(Cl)C=C1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 6/20 0.35
EPHX2 P34913 6/20 0.35
ALOX5AP P20292 1/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
ALDH1A1 P00352 1/20 0.34
PKM P14618 1/20 0.34
TP53 P04637 5/20 0.33
MAPT P10636 3/20 0.33
ALPI P09923 1/20 0.33
HTT P42858 1/20 0.32
NTRK1 P04629 1/20 0.32
RAF1 P04049 1/20 0.32
GAA P10253 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20103607 0.82 ALOX5 (0.51) ALOX5EPHX2ALOX5APMEN1KMT2A
SCHEMBL20103613 0.73 ALOX5 (0.47) ALOX5EPHX2ALOX5APMEN1KMT2A
SCHEMBL20103477 0.68 EPHX2 (0.55) ALOX5EPHX2ALOX5APMEN1KMT2A
SCHEMBL20103462 0.66 NPC1 (0.47) MEN1KMT2AALDH1A1PKMTP53
SCHEMBL18711197 0.64 PPARG (0.40) MEN1KMT2ATP53MAPTGAA
SCHEMBL368032 0.63 CYP1A2 (0.45) MEN1KMT2AALDH1A1MAPT
SCHEMBL14838247 0.63 CYP1A2 (0.47) MEN1KMT2AALDH1A1TP53MAPT
SCHEMBL14300652 0.62 CYP1A2 (0.46) MEN1KMT2AALDH1A1MAPTGAA
SCHEMBL4065436 0.61 CNR2 (0.46) MEN1KMT2AALDH1A1MAPT
SCHEMBL6095249 0.61 MAPT (0.47) ALDH1A1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3315495-A1 N,N' -DIARYLUREA, N,N' -DIARYLTHIOUREA AND N,N' -DIARYLGUANIDINO COMPOUNDS FOR USE IN TREATMENT AND PREVENTION OF INFLAMMATORY DISEASE Universität Innsbruck (AT) 2018-05-02 EP disclosed